Randomized Controlled Study on Mandala Coloring for Quality of Life in Epilepsy
Summary
NIH registered a randomized controlled trial (NCT07540013) to assess mandala painting's effect on quality of life in epilepsy patients. The single-blind study at Gümüşhane State Hospital Neurology Polyclinic will enroll adult patients with generalized epilepsy, randomly assigning them to control or experimental groups via full simple randomization. The experimental group will receive mandala painting materials and instructions to complete one mandala at home three times weekly over twenty-four sessions, with data collected using the QOLIE-31 quality-of-life scale.
What changed
NIH registered a new randomized controlled trial on ClinicalTrials.gov (NCT07540013) investigating mandala art therapy's impact on quality of life in adult epilepsy patients. The single-blind study at Gümüşhane State Hospital Neurology Polyclinic will use simple randomization to assign participants to control or experimental groups, with the experimental group completing mandala painting three times weekly for twenty-four sessions. Quality of life will be measured using the QOLIE-31 scale.
Healthcare providers and researchers should note this study as an example of non-pharmacological adjunct interventions being formally evaluated for epilepsy management. Art-based therapies are gaining interest as complementary approaches alongside antiepileptic medications. The study does not impose any regulatory obligations but contributes to the evidence base for integrative approaches in neurology.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
The Effect of Mandala Coloring on the Quality of Life in Epilepsy Patients: A Single Blind Randomized Controlled Study
N/A NCT07540013 Kind: NA Apr 20, 2026
Abstract
Epilepsy is among the most prevalent and serious neurological disorders. While antiepileptic medications play a crucial role in managing the condition, additional support through counseling, education, cognitive behavioral therapy, and social assistance for both patients and their families is essential. Furthermore, incorporating art-based interventions is vital due to their beneficial effects on life quality and their significance in health promotion and prevention. Research suggests that art therapy can aid patients in managing their symptoms and enhancing their overall well-being. Currently, mandalas are being effectively utilized in art therapy practices. However, a review of the literature reveals a lack of studies examining the impact of mandala art therapy on the quality of life for individuals with epilepsy. This randomized controlled trial aims to assess how mandala painting influences the quality of life in epilepsy patients. The study will involve adult epilepsy patients from Gümüşhane State Hospital Neurology Polyclinic. Participants will be randomly assigned to either a control group or an experimental group using a lottery method, known as "Full (Simple) Randomization." Data will be gathered through a patient information form and the "Quality of Life Scale in Epilepsy (QOLIE-31)." The experimental group will receive materials for mandala painting and will be instructed to complete one mandala at home three times a week over the course of twenty-four sessions ...
Conditions: Epilepsy, Generalized
Interventions: Art therapy(Mandala)
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.